The FDA announced on 2022-11-18 that Ventana Medical Systems, Inc. is recalling VENTANA PD-L1 (SP142) Assays due to light staining that may cause false-negative results. The recall affects 8,927 kits distributed worldwide.
How to tell if you have it
- Brand: Ventana
- Product: VENTANA PD-L1 (SP142) Assay (Class III, US IVD) 07709374001
- Product: VENTANA PD-L1 (SP142) Assay (CE IVD Predictive) 08008540001
- Product: VENTANA PD-L1 (SP142) IHC Assay (CE IVD Analytical) 07011571001
- UDI-DI Code: 04015630967155
- Lot codes: F30596, G27114, G31438, H03958, H13049, H35110, J12769, J18775, J25361
- UDI-DI Code: 07613336106709
- Lot codes: F31427, G06715, G16831, G24564, H00001, H07164, H15132, H18578, J00572, J01568, J14244, J20989
- Lot codes: H08373
- UDI-DI Code: 04015630976591
- Lot codes: H17865, H30521, H35111, J11932, J20132
The hazard
Internal comparison studies revealed unacceptable light staining that affects the borderline of positive versus negative test results. This reduction in staining intensity and percent positivity could potentially lead to a false-negative PD-L1 result.
Context
GovInfoNow's records show Ventana Medical Systems, Inc. has 7 other recalls on record since 2017-12-19. Other recent recalls of similar products include Ventana navify Digital Pathology v2.5 Software Image Discrepancy Recall (2026-04-20), Ventana anti-CD10 antibody recall (2024-06-27), and Ventana HE : Fluid Leak Risk Could Cause Fire in Lab Equipment (2022-06-01). Other recent recalls of similar products include Hologic Aptima HPV Assay Kit Recall (2026-02-18), Siemens Healthcare Syva EMIT 2000 Quinidine Assay Recall (2026-07-13), and Diagnostica Stago Asserachrom HPIA Kit Recall (2025-12-15).